CRO

SynteractHCR expands in adaptive trials; Cobra partners with Recopharma;

> SynteractHCR has expanded its adaptive trials capabilities, allowing clients to adjust study parameters without sullying results. More

> Cobra Biologics has signed a deal to supply proteins for human cell lines to Recopharma. News

> German CRO ICRC-Weyer has added drug safety services to its platform of clinical research. Item

> Australia's Novotech has expanded its partnership with Medidata Solutions, using the company's software for trial data management and randomization. Story